Capital Markets

We advise issuers, underwriters, sponsors and boards, who trust us for our cut-through and quality advice on complex equity and debt capital markets transactions.

How we can help

We are the capital markets experts, providing swift, commercial and expert advice on equity and debt capital markets and securitisation transactions across all sectors.

With the deepest bench strength in Australia, our team understands the needs and objectives of issuers, underwriters and investors. This knowledge delivers thoughtful, strategic and decisive guidance and successful outcomes.

We have strong connections with all major Australian investment banks and key regulators including ASIC, the ASX and APRA. These relationships ensure clear insight into any key issues and efficient process to resolve them.

We lead the market on our execution speed, innovative thinking and client-centric approach.

Services

Our expert deal progression and risk management helps capital markets participants succeed. We leverage deep experience and strong regulatory connections for cut-through and next-level responsiveness.

Equity capital markets

Advice on IPOs, secondary raisings, block trades, market exits, buybacks, capital management transactions, dividend plans, employee share plans and regulatory compliance, including disclosure and governance for listed entities.

Debt capital markets

Advice on various programme establishments, drawdowns, credit-wrapped notes, US private placements and bonds.

Derivatives

Advice on swaps, options, futures, forwards, structured products, regulatory compliance, risk management, trading strategies and documentation for various derivative transactions.

Securitisation

Advice on RMBS, CMBS, asset-backed securities, auto loans, hire purchase, lease receivables, insurance premium loans and whole business transactions.

Capital Markets experience

Sigma Healthcare

On its $9 billion reverse takeover and ASX listing of Chemist Warehouse.

Guzman y Gomez

On its $3 billion IPO and ASX listing.

Metals Acquisition

On its $325 million IPO in Australia and dual listing on the ASX.

Macquarie Capital and Morgan Stanley

As joint lead managers to the $650 million IPO and ASX listing of HealthCo Healthcare and Wellness REIT (a spin-off of Home Consortium).

Jefferies and Bell Potter

As joint lead managers and underwriters of Clarity Pharmaceutical’s $258 million IPO and ASX listing.

J.P. Morgan and Morgan Stanley

As joint lead managers on Tyro’s $1.37 billion IPO and ASX listing.

Orica

On its $400 million placement and $65 million SPP to partially fund the US$640 million acquisition of Cyanco.

Opthea

On its $227 million ANREO and institutional placement to help fund the company through the anticipated Phase 3 topline data readouts, and to progress chemistry, manufacturing and controls activities, preparations for FDA approval and general corporate purposes.

De Grey Mining

In relation to its $344 million placement and 1-for-7.95 pro-rata Accelerated Non-Renounceable Entitlement Offer (ANREO) raising $600 million total, the funding will help maintain momentum in advancing the Hemi Gold Project towards production.

Goldman Sachs, Morgan Stanley and UBS

As joint lead managers and underwriters on carsales.com’s $1.2 billion ANREO to fund its acquisition of the remaining 51% interest in Trader Interactive.

Morgan Stanley and Barrenjoey

As joint lead managers, bookrunners and underwriters to APA Group’s $750 million ‘pro rata’ institutional placement to partly fund its acquisition of Alinta Energy’s Pilbara assets.

Jarden Australia

In relation to its role as sole lead manager and underwriter of Syrah Resources $98 million ANREO and placement to cover costs at Syrah’s Vidalia facility, as well as to provide working capital for Balama.

West African Resources

In relation to its placement to institutional and sophisticated investors to raise up to $150 million to fund pre-production activities at its Kiaka Gold Project.

Crescent Capital Partners

On its $130 million block trade of its shares in Australian Clinical Labs.

Bank of America

On its role as lead manager and underwriter to the $68 million block trade in Regis Healthcare shares by co-founder Bryan Dorman.

Xero

On its US$925 million convertible notes issuance and concurrent partial buyback of existing notes for US$618 million and new call spread transactions.

Anheuser-Busch InBev

On the establishment of a $3 billion AMTN Program for its Australian subsidiary FBG Finance Pty and the inaugural issue of $700 million following an Exchange offer.

Pioneer Credit

On two debt portfolio acquisitions, one being a Park IX (Insolvency) debt portfolio.

Leighton Finance

On the establishment of its $1 billion MTN Program and following issues under the Program.

Optus Finance

On the establishment of its €2 billion EMTN Programme and following issues under the Programme.

PIUS

On the inaugural roll out of its US$60 million Clip Notes Structure in Australia to Carbon Revolution as part of a restructure and relisting of the Carbon Revolution Group.

Acacia Partners

On a recent landmark DCM issuance in the Australia legal market.

Major Australian corporates

Alinta Energy, GrainCorp, Leighton, Transfield, Virgin Blue, Centennial Coal, Centro, Origin, RailCorp, Bank of Queensland and NBN Co on advising, documenting derivatives agreements and preparing templates.

Origin

In connection with derivatives including advising on and documenting underlying derivatives agreements for both domestic and offshore derivatives and preparing template documentation.

RailCorp

In connection with derivatives including advising on and documenting underlying derivatives agreements for both domestic and offshore derivatives and preparing template documentation.

Schroders

On derivative-based products, advising on and documenting underlying derivatives agreements for domestic and offshore structured fund products, preparing template documents for regional derivatives.

Sovereign funds

On derivative-based products, advising on and documenting derivatives agreements for domestic and offshore derivative and structured fund products, and preparing regional template documentation.

Transfield

In connection with derivatives including advising on and documenting underlying derivatives agreements for both domestic and offshore derivatives and preparing template documentation.

Financial institutions

On the domestic lease securitised financing of Holden’s High Feature V6 Engine Plant in Melbourne and advising CBA in the structured financing of ION’s engine block plant in Altona.

Barclays Bank

On the securitisation financing in connection with Blackstone’s acquisition financing of Crown Resorts.

Equity Trustees

In providing trustee, security trustee, back-up servicer and trust manager services as part of a $304.5 million public asset backed securitisation.

GrainCorp

On its takeover bid by Long-Term Asset Partners, involving a unique multi-decade 'swap' resembling securitisation, with limited equity, mezzanine and secured debt, and derivatives to manage weather risk.

A major bank

On the establishment of a master trust securitisation programme, set up to fund the client group via the sale of insurance commission receivables originated by an entity within the client group.

A major Australian bank

On its $700 million hybrid securities issue, securitising Colonial State Funds Management's embedded value, and advising on various RMBS issuances under the Medallion Program into global markets.

Awards